Today: 22 January 2026
Subscribe
Browse Category

Stocks News 1 January 2026 - 2 January 2026

CoreWeave (CRWV) stock in focus as insider sale filing lands ahead of Friday open

CoreWeave (CRWV) stock in focus as insider sale filing lands ahead of Friday open

NEW YORK, Jan 2, 2026, 06:38 ET — Premarket CoreWeave shares were flat at $71.61 in premarket trading on Friday, after sliding 3.1% in the previous session. The stock is starting the new year under a bright spotlight because investors have grown sensitive to insider selling at fast-growing, capital-intensive AI infrastructure firms, where funding needs can move sentiment quickly. That…
2 January 2026
···
Novo Nordisk stock slips premarket as China court backs key semaglutide patent

Novo Nordisk stock slips premarket as China court backs key semaglutide patent

NEW YORK, January 2, 2026, 05:42 ET — Premarket Novo Nordisk A/S shares edged lower in premarket trading on Friday after the Danish drugmaker said China’s Supreme People’s Court upheld a key patent covering semaglutide, the active ingredient in its blockbuster obesity and diabetes drugs. U.S.-listed American depositary receipts (ADRs) — certificates that represent foreign shares — were down about…
2 January 2026
··
SELLAS (SLS) stock jumps about 10% in premarket as REGAL AML trial milestone stays in focus

SELLAS (SLS) stock jumps about 10% in premarket as REGAL AML trial milestone stays in focus

NEW YORK, January 2, 2026, 05:03 ET — Premarket SELLAS Life Sciences Group (SLS) shares rose about 10% in U.S. premarket trading on Friday to $4.14, after gaining 13.9% in the prior regular session. Early trading ranged between $4.13 and $4.32. Public The move matters because SELLAS’ valuation hinges on a single late-stage cancer study, and timing signals can drive…
2 January 2026
····
Cytokinetics (CYTK) stock closes up 3.5% into year-end as Myqorzo launch nears, insider sale disclosed

Cytokinetics (CYTK) stock closes up 3.5% into year-end as Myqorzo launch nears, insider sale disclosed

NEW YORK, January 1, 2026, 21:17 ET — Market closed Cytokinetics, Incorporated shares ended Wednesday up 3.5% at $63.54, the final U.S. trading session of 2025, after markets closed Thursday for the New Year’s Day holiday. The stock has traded between $29.31 and $70.98 over the past 52 weeks, according to market data. New York Stock Exchange The year-end move…
2 January 2026
····
Denison Mines stock today: DNN ends 2025 higher ahead of Friday reopen

Denison Mines stock today: DNN ends 2025 higher ahead of Friday reopen

NEW YORK, January 1, 2026, 21:05 ET — Market closed Denison Mines Corp’s U.S.-listed shares last ended up about 1% at $2.66 on Wednesday, the final U.S. trading session of 2025. The NYSE American-listed stock traded between $2.61 and $2.68, with about 22 million shares changing hands, LSEG data showed. U.S. stock and bond markets were closed on Thursday for…
2 January 2026
····
MARA stock slides into 2026 after share-plan filing as bitcoin steadies near $88,000

MARA stock slides into 2026 after share-plan filing as bitcoin steadies near $88,000

NEW YORK, January 1, 2026, 20:10 ET — Market closed MARA Holdings, Inc (MARA) shares fell 3.6% in the last U.S. session of 2025, closing at $8.98 after trading between $8.96 and $9.40. U.S. markets were shut on Thursday for New Year’s Day. Traders often treat MARA as a leveraged proxy for bitcoin because miners earn bitcoin by running specialized…
2 January 2026
····
Wheaton Precious Metals stock slips as gold cools into 2026; Fed and jobs data loom for WPM

Wheaton Precious Metals stock slips as gold cools into 2026; Fed and jobs data loom for WPM

NEW YORK, January 1, 2026, 18:11 ET — Market closed Wheaton Precious Metals Corp shares (WPM) last closed down 1.2% at $117.52 on Wednesday, with U.S. markets shut on Thursday for New Year’s Day. Yahoo Finance The late-year dip followed profit-taking across precious metals after a standout 2025, when gold climbed 66% and silver gained 161%, Reuters reported. Reuters That…
2 January 2026
···
Synopsys stock (SNPS) heads into 2026 down 1% — what traders watch next

Synopsys stock (SNPS) heads into 2026 down 1% — what traders watch next

NEW YORK, January 1, 2026, 17:06 ET — Market closed. Synopsys shares last closed down about 1% at $469.72 on Wednesday, with U.S. markets shut on Thursday for the New Year’s Day holiday. Reuters The move matters because the chip-design software group is being pulled between two forces: continued spending tied to artificial intelligence hardware and a late-year wobble in…
1 January 2026
····
Western Digital stock slips into 2026 after year-end profit-taking in AI storage winners

Western Digital stock slips into 2026 after year-end profit-taking in AI storage winners

NEW YORK, January 1, 2026, 16:20 ET — Market closed Western Digital Corp shares fell 2.2% to $172.27 in the final trading session of 2025, and were not trading on Thursday with U.S. markets closed for New Year’s Day. Reuters The late slide came after the data-storage maker’s stock more than tripled in 2025, a year in which investors piled…
1 January 2026
···
Energy stocks today: Oil’s steep 2025 slide weighs on XLE as OPEC+ meeting nears

Energy stocks today: Oil’s steep 2025 slide weighs on XLE as OPEC+ meeting nears

NEW YORK, January 1, 2026, 1:54 PM ET — Market closed Energy stocks ended 2025 weaker, tracking a late-year slide in crude that left oil prices with their steepest annual drop since 2020. U.S. markets are shut on Thursday for New Year’s Day, leaving investors to recalibrate positions ahead of Friday’s reopening. Reuters The timing matters because many energy shares…
1 January 2026
··
1 … 29 30 31 32 33 … 90

Stock Market Today

  • RBB Shares Surge 5.1% Amid Tariff-Relief Rally, Earnings Expectations in Focus
    January 22, 2026, 9:48 AM EST. RBB shares rallied 5.1% to $22.33, reversing recent losses on high trading volume following tariff relief news linked to Greenland. The bank holding company's upcoming quarterly earnings report projects 96% year-over-year EPS growth to $0.49 and revenues up 14.7% to $32.94 million. However, consensus earnings estimates have remained flat over the past month, which may limit sustained price momentum absent positive revisions. RBB holds a Zacks Rank #3 (Hold) amid sector peers like Bank of Marin, which gained 5% with an improving earnings outlook and a Rank #1 (Strong Buy). Investors should monitor earnings estimate trends closely to assess whether RBB's recent jump can extend further.
Go toTop